{
  "title": "Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Finds",
  "link": "https://www.nytimes.com/2022/11/09/health/opioid-addiction-treatment-racial-disparities.html",
  "guid": "https://www.nytimes.com/2022/11/09/health/opioid-addiction-treatment-racial-disparities.html",
  "atom:link": "",
  "description": "The analysis of 15 years of prescription data showed that the racial disparities are widening.",
  "dc:creator": "Emily Baumgaertner",
  "pubDate": "Wed, 09 Nov 2022 17:28:16 +0000",
  "category": [
    "your-feed-science",
    "Buprenorphine (Drug)",
    "Research",
    "Drugs (Pharmaceuticals)",
    "Race and Ethnicity",
    "Hispanic-Americans",
    "Minorities",
    "Black People",
    "Opioids and Opiates",
    "Addiction (Psychology)",
    "Whites",
    "Drug Abuse and Traffic",
    "United States"
  ],
  "media:content": "",
  "media:credit": "Ruth Fremson/The New York Times",
  "media:description": "Researchers agreed the duration of treatment for all groups were far lower than the recommended six months. For white patients, the median treatment duration was about 53 days; for Black patients, about 44 days; and for Hispanic patients, less than 40."
}